EKF Diagnostics highlight new clinical chemistry analyzer at Arab Health 2016

EKF Diagnostics, the global in vitro diagnostics company, will be highlighting its new Altair™ 240 clinical chemistry analyzer alongside many of its other point-of-care (POC) and laboratory diagnostics products at Arab Health 2016, Dubai, 25 - 28th January. The new fully automated Altair 240 bench-top analyzer will be available for demonstrations and discussion on Stand Z1G30 (Zabeel Hall 1). Also on the stand, EKF product specialist Trevor McCarthy will be presenting a ‘Clinical Chemistry Product Portfolio Update’ in a series of daily lunch and learn sessions.

Available globally, the Altair is a compact, open-channel, automatic random access analyzer which is supported by a full-range of bar-coded, liquid-stable, ready-to-use Stanbio Chemistry reagents. Waste is minimized since it uses reusable cuvettes and most reagents have a 30-day on-board stability. Running up to 400 tests per hour (with an optional Ion Sensitive Electrode (ISE) module) with positions for 43 reagents and the ability to configure open channels for esoteric testing needs, the Altair™ 240 provides a comprehensive clinical chemistry solution for a variety of settings.

Also at Arab Health, EKF will be discussing its portfolio of products used in Diabetes Care. This includes POC analyzers which deliver fast and reliable results for glycated hemoglobin (HbA1c) and glucose, enabling both practitioner and patient to make clinical or lifestyle decisions in minutes. The EKF Diabetes Care portfolio also includes clinical chemistry used in diabetes care such as Beta-Hydroxybutyrate LiquiColor® (B-HB) reagent, and Glycated Serum Protein (GSP) which provides a two to three week indicator of average blood glucose.

On Stand Z1G30 (Zabeel Hall 1), Trevor McCarthy, Business Segment Manager for Central Laboratory, will be giving a ‘Clinical Chemistry Product Portfolio Update’ on the new Altair 240 clinical chemistry analyzer, as well as B-HB, GSP and PCT (procalcitonin) liquid reagents. These lunchtime presentations will take place on Tuesday, Wednesday and Thursday of the show from 12:30-13:30, with refreshments followed by a Q&A session. Visitors will also have the opportunity to see EKF's Point-of-care range, including Quo-Lab™ and Quo-Test™ HbA1c analyzers, as well as its Biosen series of glucose analyzers and Hemo Control hemoglobin analyzer.

“We look forward to welcoming visitors at Arab Health to our stand and demonstrating how our broad range of point-of-care and central laboratory products have earned a well-deserved reputation globally for ease of use, reliability and accuracy,” commented Trevor McCarthy. “For example, 80,000 of our POC analyzers are used regularly in over 100 countries to run more than 50 million tests annually, and our B-HB reagent is used frequently on open channel analyzers in 1,100 hospitals in the United States alone.”

Back to ListingPreviousNext